Citadel Advisors’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.8M Buy
58,200
+30,900
+113% +$2.3M ﹤0.01% 4809
2025
Q4
$2.16M Sell
27,300
-105,375
-79% -$8.07M ﹤0.01% 5751
2025
Q3
$9.69M Sell
132,675
-40,475
-23% -$2.97M ﹤0.01% 3326
2025
Q2
$13.1M Sell
173,150
-29,200
-14% -$2.07M ﹤0.01% 2675
2025
Q1
$15.4M Sell
202,350
-30,225
-13% -$2.25M ﹤0.01% 2328
2024
Q4
$15.4M Sell
232,575
-79,375
-25% -$5.56M ﹤0.01% 2454
2024
Q3
$21.7M Sell
311,950
-2,850
-0.9% -$171K ﹤0.01% 1961
2024
Q2
$16.6M Buy
+314,800
New +$19.1M ﹤0.01% 2188

Other funds holding SOLV

Citadel Advisors's SOLV Position: Q1 2026 in Review

Citadel Advisors increased its Solventum (SOLV) stake by 431% in Q1 2026, buying an estimated $36.1M and bringing the position to 599,078 shares worth $39.1M. The position accounts for 0.01% of the portfolio, ranked #1585.

Citadel Advisors first reported a position in SOLV in Q1 2024 and has held it in 8 quarters since. The position peaked at $114M in Q3 2025. 877 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Citadel Advisors held 599,078 shares of Solventum worth $39.1M as of Q1 2026.
  • Citadel Advisors bought 486,233 Solventum shares in Q1 2026, an estimated $36.1M.
  • Solventum made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1585 holding.
  • Citadel Advisors first reported a position in Solventum in Q1 2024 and has held it in 8 quarters since.
  • Citadel Advisors's Solventum position peaked at $114M in Q3 2025.
  • 877 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.